Pharmagreen Biotech Aims to Update Its Shareholders on Company Focus on CBD Hemp Industry
CARSON CITY, NV, Jan. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Pharmagreen Biotech, Inc. (OTC: PHBI), a company specializing in the development of high quality tissue cultured starter plantlets, CBD oils, formulations and isolates from hemp plants announced today that we are changing our emphasis to targeting hemp and the CBD industry. “After taking much time to carefully analyze our strategic options, we have decided that immediate business development in the hemp in